Ariad Pharma (ARIA) Posts Wider than Expected Q2 Loss of 31c/Share
Tweet Send to a FriendGet Alerts ARIA Hot Sheet
Price: $19.10 +3.64%
EPS Growth %: -24.1%
Financial Fact:
Net income (loss): -64.67M
Today's EPS Names:
BOSC, GASS, AAP, More
EPS Growth %: -24.1%
Financial Fact:
Net income (loss): -64.67M
Today's EPS Names:
BOSC, GASS, AAP, More
Trade ARIA Now!
Ariad Pharma (NASDAQ: ARIA) reported Q2 EPS of ($0.31), $0.04 worse than the analyst estimate of ($0.27).
For earnings history and earnings-related data on Ariad Pharma (ARIA) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
For earnings history and earnings-related data on Ariad Pharma (ARIA) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Hewlett-Packard Company (HPQ) Tops Q2 EPS by 6c as Sales Slide 10%
- Perry Ellis Int'l (PERY) Misses Q1 EPS by 1c; Reaffirms Outlook
- UPDATE: 8x8 Inc. (EGHT) Misses Q4 EPS by 1c
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
